SOURCE: Targeted Genetics

May 01, 2007 07:30 ET

Targeted Genetics to Host Conference Call and Webcast Discussion of First Quarter 2007 Results on May 9, 2007

SEATTLE, WA -- (MARKET WIRE) -- May 1, 2007 -- Targeted Genetics Corporation (NASDAQ: TGEN) will report its first quarter 2007 financial results on Wednesday, May 9, 2007, before the open of the financial markets. Following the announcement, management will host a conference call and webcast discussion of the financial results and provide a general corporate update beginning at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time. You may access the live webcast via the "Events" section of the Company's website at or via telephone at 800.240.7305 (domestic) or 303.262.2211 (international).

Replay Access

Webcast replay will be available for approximately 30 days at; telephone replay will be available following Wednesday's call at approximately 12:30 p.m. ET through 11:59 p.m. ET, Saturday, June 9, 2007, by calling 800.405.2236 (domestic) or 303.590.3000 (international); passcode 11089229#.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contact:
    Stacie D. Byars
    Director, Communications
    Targeted Genetics Corporation
    (206) 521-7392